Why Mylan’s ‘savings card’ won’t make EpiPen cheaper for all patients

August 25, 2016 1:52 PM

31 0

After being blasted for price hikes on its lifesaving EpiPen allergy injections, the drugmaker Mylan announced Thursday that it will expand access to the product — not by lowering the price, but by creating a savings card that will cover up to $300 of its EpiPen 2-Pak.

The list price of the drug is $609 for a two-pack of the injectors, up from less than $100 in 2007, according to data from Truven Health Analytics.

Also read: FDA approves BioMarin rare metabolic disorder drug, shares rise

Read more

To category page